Janki Gabani
About Janki Gabani
Janki Gabani is a QC Microbiologist with a strong educational background in biology and biotechnology, holding multiple degrees from institutions including The University of Texas at Arlington and CHAROTAR UNIVERSITY OF SCIENCE AND TECHNOLOGY. She has professional experience in microbiology and laboratory representation, currently working at Marker Therapeutics, Inc. in Houston, Texas.
Work at Marker Therapeutics
Janki Gabani currently serves as a QC Microbiologist at Marker Therapeutics, Inc. since 2021. In this role, she is responsible for ensuring the quality and safety of microbiological products. Marker Therapeutics focuses on developing innovative cell therapies for cancer treatment, and the QC Microbiologist plays a crucial role in maintaining compliance with industry standards and regulations.
Education and Expertise
Janki Gabani holds a Master of Science in Biology from The University of Texas at Arlington, which she completed from 2019 to 2020. Prior to this, she earned a Master of Science in Biotechnology from Charotar University of Science and Technology between 2011 and 2013. Her academic journey began with a Bachelor of Science in Biochemistry and Vocational Biotechnology from Gujarat University, completed from 2008 to 2011. This educational background provides her with a solid foundation in biological sciences and microbiology.
Background
Janki Gabani has a diverse professional background in microbiology and biotechnology. She began her career as a Laboratory Representative at P. D. Patel Institute of Applied Sciences in Gujarat, India, from 2011 to 2013. Following this, she worked as a QC Microbiologist at Cadila Pharmaceuticals Limited from 2014 to 2017, where she gained significant experience in quality control processes within the pharmaceutical industry.
Professional Experience
Janki Gabani has accumulated extensive experience in the field of microbiology over the years. After her role at P. D. Patel Institute of Applied Sciences, she worked at Cadila Pharmaceuticals Limited for three years, focusing on quality control microbiology. Her current position at Marker Therapeutics further enhances her expertise in the field, where she applies her knowledge to ensure product quality in a biopharmaceutical setting.